Stock Analiz

Cullinan Therapeutics, Inc. (CGEM) stock forecast and price target

Price $10.28 · data as of November 13, 2026

12-month price target

Average target$34.27
Upside / downside+233.4%
Analysts11
ConsensusStrong buy
Low $27.00Average $34.27High $44.00

Gold marker: average target · white marker: today’s price ($10.28)

Analyst ratings

Strong buy 1Buy 11Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-3.01+10.5%$0
Next fiscal year
ends December 31, 2027
$-2.40+20.2%$56M
Quarter after
ends December 31, 2026
$-0.63+18.6%$20M

Consensus of the analysts covering Cullinan Therapeutics, updated daily. In the last 30 days 3 estimates were raised and 0 lowered.

Frequently asked questions

What is the Cullinan Therapeutics stock price target?

The average 12-month target from 11 analysts is $34.27, 233.4% above the current price of $10.28 Targets range from $27.00 to $44.00.

Is Cullinan Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 11 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Cullinan Therapeutics expected to earn?

Analysts expect EPS of $-3.01 for the fiscal year ending December 31, 2026 and $-2.40 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.